Answer
Dexrazoxane chelates iron, especially through its ring-opened metabolite, reducing iron-dependent oxidative stress causing anthracycline-induced cardiotoxicity, and inhibits topoisomerase II; each mechanism’s contribution to preventing tissue destruction after anthracycline extravasation is unknown.
Sources for this answer
- Savene 20 mg/ml powder and solvent for concentrate for solution for infusionCNX Therapeutics Ltd (formerly Sunovion Pharmaceuticals Europe) · emc · SmPC §5.1 Pharmacodynamic properties · Version 1Document updated
Sources checked